Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Italy / NCT03807687
Recruiting Observational

Registry of Pancreatic Disease

NCT03807687 · tracked via the Priya Life Science Italy tracker
Sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Phase
Observational
Started
2016-12-01
Last updated
2019-01-17

Condition(s) studied

Pancreatic DiseasesPancreatic NeoplasmsPancreatitis

Study summary

This clinical data registry records information about the health status and healthcare performances received by participants affected by every type of pancreatic disease or disorder. All data (demographic, clinical, biochemical, radiological, pharmacological, genetic...) and audio and/or video recording from operative room are collected in order to be used for prospective or retrospective studies.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * any type of pancreatic disease: inflammatory and neoplastic (including solid and cystic lesions) Exclusion Criteria: * physically or mentally inability to provide consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
AOUI Verona Verona Italy Recruiting

More Azienda Ospedaliera Universitaria Integrata Verona trials in Italy

Trial to Compare Different Strategies of Mean Arterial Pressure Management During Cardiopulmonary By-pass Recruiting
Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K) Recruiting
PIPAC in Multimodal Therapy for Patients with Oligometastatic Peritoneal Gastric Cancer Recruiting
ATRX/DAXX in EUS-FNB Specimens of Pan-NETs Active, not recruiting
Verona Coronary Physiology Interventional Registry Active, not recruiting

Other trials for the same condition

Microplastics in Pancreas: Oncologic and Metabolic Impact Starting soon
Patient Reported Experience in Endoscopic Ultrasound Active, not recruiting
EUS-Based Artificial Intelligence to Predict Outcomes in Pancreatic Cancer Starting soon
Iconographic Registry of Pancreatobiliary Endoscopy Procedures Recruiting
Activation of Biobank Registry for Bilio-pancreatic Diseases Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03807687 on ClinicalTrials.gov ↗ ← All trials in Italy